Article

A versatile product: FDA approves botulinum toxin for glabellar lines

Irvine, CA-The FDA has approved the use of botulinum toxin type A (Botox, Allergan, Irvine, CA) for temporary improvement in the appearance of moderate to severe glabellar lines in adult men and women 65 or younger.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
Related Content
HIV drug lamivudine shows promise in treating diabetic macular edema
June 12th 2025

HIV drug lamivudine shows promise in treating diabetic macular edema

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Qlaris Bio announces development of QLS-111-FDC
June 12th 2025

Qlaris Bio announces development of QLS-111-FDC

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

NIH study identifies brain circuits critical to visual acuity beyond the retina
June 12th 2025

NIH study identifies brain circuits critical to visual acuity beyond the retina

Study shows ceftriaxone found effective in treating congenital syphilis
June 11th 2025

Study shows ceftriaxone found effective in treating congenital syphilis

© 2025 MJH Life Sciences

All rights reserved.